Zusammenfassung
Synkopen sind im Kindesalter häufig. Affektkrämpfe, vasovagale Synkopen, neurogene und neurokardiogene Synkopen basieren auf einem gemeinsamen Pathomechanismus und werden unter dem Begriff neurogene Synkopen zusammengefasst. Neurogene Synkopen liegen bei ca. 75 % der Synkopen im Kindesalter vor. Eine kardiale Synkope besteht in bis zu 6 % der Fälle. Die Differenzierung zwischen einer benignen Ursache und einer unter Umständen lebensbedrohlichen Ursache der Synkope gelingt in der überwiegenden Zahl der Kinder und Jugendlichen mittels detaillierter Anamnese, körperlicher Untersuchung und anhand des Ruhe-EKG. Eine Kipptischuntersuchung kann bei ungeklärter Ursache im Einzelfall zur Diagnose führen. Bei Kindern mit neurogenen Synkopen ist häufig durch eine Änderung des Lebensstils, Vermeidung der auslösenden Situationen sowie Beruhigung der Familie Symptomfreiheit zu erzielen. Bei fehlendem Effekt kann eine sympathomimetische medikamentöse Therapie mit Midodrin effektiv sein. Fludrocortison und eine antibradykarde Stimulation sind bei ausgewählten Patienten hilfreich. Eine β‑Blocker-Therapie ist nicht von Nutzen. Kardiale Ursachen sind krankheitsspezifisch zu behandeln.
Abstract
Syncope is common in children and adolescents. Neurally mediated syncope including pallid and cyanotic breath holding spells, vagovasal syncope and neurocardiogenic syncope is based on a common pathomechanism and accounts for approximately 75% of cases. A potentially life-threatening cardiac cause of syncope may be present in up to 6%. Detailed history, physical examination and 12-lead electrocardiogram (ECG) allow discrimination between benign and serious syncope in the majority of pediatric patients. Tilt-testing can be useful when diagnosis is unclear. In neurally mediated syncope, education on awareness of prodromes, modification of life-style and reassurance of the family on benign character of the disease is sufficient for preventing further syncopal episodes in the majority of cases. In pediatric patients unresponsive to these measures midodrine is often effective. Fludrocortisone and cardiac pacing may be considered in selected patients. β‑Blockers are not beneficial in pediatric neurally mediated syncope. Cardiac causes need specific disease-targeted therapy.
Literatur
Balaji S, Oslizlok PC, Allen MC et al (1994) Neurocardiogenic syncope in children with a normal heart. J Am Coll Cardiol 23:779–785
Chu W, Wang C, Wu L et al (2015) Oral rehydration salts: an effective choice for the treatment of children with vasovagal syncope. Pediatr Cardiol 36:867–872
Dimario FJ Jr. (2001) Prospective study of children with cyanotic and pallid breath-holding spells. Pediatrics 107:265–269
Dittrich S, Laser KT, Deisehofer I et al (2014) S2 Leitlinie Synkope. http://www.kinderkardiologie.org/fileadmin/user_upload/Leitlinien/LL%20Synkope%20final%20nach%20Frankfurt%2016.05.2014.pdf. Zugegriffen: 23.02.2018
Ergul Y, Tanidir IC, Ozyilmaz I et al (2015) Evaluation rhythm problems in unexplained syncope etiology with implantable loop recorder. Pediatr Int 57:359–366
Filippini L, Postema PG, Zoubin K et al (2017) The brisk-standing-test for long QT syndrome in prepubertal school children: defining normal. Europace. https://doi.org/10.1093/europace/eux259
Kanjwal K, Calkins H (2015) Syncope in children and adolescents. Cardiol Clin 33:397–409
Kelly AM, Porter CJ, Mcgoon MD et al (2001) Breath-holding spells associated with significant bradycardia: successful treatment with permanent pacemaker implantation. Pediatrics 108:698–702
Massin MM, Bourguignont A, Coremans C et al (2004) Syncope in pediatric patients presenting to an emergency department. J Pediatr 145:223–228
Mcleod KA (2003) Syncope in childhood. Arch Dis Child 88:350–353
Mcleod KA, Wilson N, Hewitt J et al (1999) Cardiac pacing for severe childhood neurally mediated syncope with reflex anoxic seizures. Heart 82:721–725
Perry JC, Friedman RA, Moak JP et al (1991) Bradycardia and syncope in children not controlled by pacing: beta-adrenergic hypersensitivity. Pacing Clin Electrophysiol 14:391–394
Priori SG, Wilde AA, Horie M et al (2013) Executive summary: HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes. Europace 15:1389–1406
Qingyou Z, Junbao D, Jianjun C et al (2004) Association of clinical characteristics of unexplained syncope with the outcome of head-up tilt tests in children. Pediatr Cardiol 25:360–364
Qingyou Z, Junbao D, Chaoshu T (2006) The efficacy of midodrine hydrochloride in the treatment of children with vasovagal syncope. J Pediatr 149:777–780
Salim MA, Di Sessa TG (2005) Effectiveness of fludrocortisone and salt in preventing syncope recurrence in children: a double-blind, placebo-controlled, randomized trial. J Am Coll Cardiol 45:484–488
Scott WA, Pongiglione G, Bromberg BI et al (1995) Randomized comparison of atenolol and fludrocortisone acetate in the treatment of pediatric neurally mediated syncope. Am J Cardiol 76:400–402
Strieper MJ, Campbell RM (1993) Efficacy of alpha-adrenergic agonist therapy for prevention of pediatric neurocardiogenic syncope. J Am Coll Cardiol 22:594–597
The Task Force for the Diagnosis and Management of Syncope of the European Society of Cardiology (ESC) et al (2009) Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J 30:2631–2671
Viskin S, Postema PG, Bhuiyan ZA et al (2010) The response of the QT interval to the brief tachycardia provoked by standing: a bedside test for diagnosing long QT syndrome. J Am Coll Cardiol 55:1955–1961
Vlahos AP, Kolettis TM (2008) Family history of children and adolescents with neurocardiogenic syncope. Pediatr Cardiol 29:227
Wieling W, Colman N, Krediet CT et al (2004) Nonpharmacological treatment of reflex syncope. Clin Auton Res 14(Suppl 1):62–70
Wren C (1999) Cardiac causes for syncope or sudden death in childhood. Arch Dis Child 81:289–291
Writing Committee Members, Shen WK, Sheldon RS et al (2017) 2017 ACC/AHA/HRS guideline for the evaluation and management of patients with syncope: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Heart Rhythm 14:e155–e217
Zhang Q, Jin H, Wang L et al (2008) Randomized comparison of metoprolol versus conventional treatment in preventing recurrence of vasovagal syncope in children and adolescents. Med Sci Monit 14:CR199–203
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
M.J. Müller und T. Paul geben an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.
Rights and permissions
About this article
Cite this article
Müller, M.J., Paul, T. Synkopen bei Kindern und Jugendlichen. Herzschr Elektrophys 29, 204–207 (2018). https://doi.org/10.1007/s00399-018-0562-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00399-018-0562-2
Schlüsselwörter
- Neurogene Synkope
- Bewusstseinsverlust
- Kurzzeitige globale zerebrale Hypoperfusion
- Pathomechanismus
- Midodrin